Julien Edeline
Julien Edeline publishes mostly in Oncology, Hepatology and Surgery, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies and Cancer Immunotherapy and Biomarkers.
- World rank
- #219,087 of 7,710,434 ranked researchers
- Rank in France
- #13,801 of 324,115
- Works
- 414
- Citations
- 19k
- Citations per work
- 45.4
What does Julien Edeline research?
Julien Edeline's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences31576.1%
- Medicine31576.1%
- Everything else8320.0%
- Life Sciences163.9%
- 1Oncology20% of their works
- 2Hepatology19% of their works
- 3Surgery17% of their works
- 4Pulmonary and Respiratory Medicine15% of their works
- 5Epidemiology4% of their works
- 6Molecular Biology4% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Colorectal Cancer Treatments and Studies
- Renal cell carcinoma treatment
- Gastric Cancer Management and Outcomes
Which keywords describe Julien Edeline's research?
The keywords of their largest research topics: Treatment, Cholangiocarcinoma, Clinical Practice Guidelines, Hepatocellular Carcinoma, Liver Cancer, Prognostic Factors, Biliary Tract Cancer and Intrahepatic Cholangiocarcinoma.
- Gastric Cancer
- Renal Cell Carcinoma
- KRAS Mutations
- Molecular Characterization
- Cholecystitis
- Pancreatic Cancer
- Immune Checkpoint Blockade
- Tumor Microenvironment
- Intrahepatic Cholangiocarcinoma
- Prognostic Factors
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Treatment
- Clinical Practice Guidelines
- Liver Cancer
- Biliary Tract Cancer
- Chemotherapy
- Immunotherapy
- PD-1 and PD-L1
- Surgical Complications
- ERCP
- Cetuximab
- Metastatic
- Endoscopic Resection
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Treatment1972 topics
- Cholangiocarcinoma1962 topics
- Clinical Practice Guidelines1902 topics
- Hepatocellular Carcinoma1691 topic
- Liver Cancer1691 topic
- Prognostic Factors1682 topics
- Biliary Tract Cancer1401 topic
- Intrahepatic Cholangiocarcinoma1401 topic
- Chemotherapy1273 topics
- Tumor Microenvironment1242 topics
- Immunotherapy892 topics
- Immune Checkpoint Blockade631 topic
- PD-1 and PD-L1631 topic
- Pancreatic Cancer611 topic
- Surgical Complications611 topic
- Cholecystitis561 topic
- ERCP561 topic
- Molecular Characterization492 topics
- Cetuximab451 topic
- KRAS Mutations451 topic
- Metastatic281 topic
- Renal Cell Carcinoma281 topic
- Endoscopic Resection211 topic
- Gastric Cancer211 topic
Where does Julien Edeline work?
Julien Edeline's main affiliation in the publication record is Centre Eugène Marquis, France.
How many publications and citations does Julien Edeline have?
OpenAlex counts 414 works and 18,778 citations for Julien Edeline, an h-index of 53, ranking #219,087 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Julien Edeline. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.